WO2000029604A1 - Production de matiere vivante par respiration aerobie et anaerobie simultanee - Google Patents

Production de matiere vivante par respiration aerobie et anaerobie simultanee Download PDF

Info

Publication number
WO2000029604A1
WO2000029604A1 PCT/US1999/026950 US9926950W WO0029604A1 WO 2000029604 A1 WO2000029604 A1 WO 2000029604A1 US 9926950 W US9926950 W US 9926950W WO 0029604 A1 WO0029604 A1 WO 0029604A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture medium
group
oxygen
acid
microorganism
Prior art date
Application number
PCT/US1999/026950
Other languages
English (en)
Inventor
Lu-Kwang Ju
Original Assignee
The University Of Akron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Akron filed Critical The University Of Akron
Priority to AU17228/00A priority Critical patent/AU1722800A/en
Publication of WO2000029604A1 publication Critical patent/WO2000029604A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Definitions

  • the present invention relates to the production of biological materials by microorganisms.
  • the present invention more particularly relates to a process for the preparation of biological products, such as biosurfactants, by microorganisms under simultaneous aerobic and anaerobic respiring conditions.
  • Cells are the real workers in biological processes. To increase process productivity, it is desirable to grow the cells to concentrations as high as possible. For aerobic biological processes, the cell concentrations employable are most commonly limited by the rate of oxygen transfer to the cell population that is achievable by a particular process. Therefore, the productivity of biological materials by aerobic fermentation processes is directly limited by the oxygen supply to the cells.
  • oxygen gas is only slightly soluble in aqueous media and, therefore the supply of oxygen must be replenished by inefficient mass transfer across the gas/liquid interface. This is traditionally achieved by vigorous aeration and/or agitation to promote the interfacial transfer of oxygen from gas bubbles to the aqueous media.
  • Aeration is employed using sterile air to provide oxygen to the fermentation solution.
  • the reference discloses that it is necessary to add a suitable anti-foaming agent to the fermentation solution during the fermentation process.
  • the L-rhamnose is recovered directly from the culture solution by hydrolysis of the rhamnolipids, without separation of the cell material and without isolation of the rhamnolipids before hydrolysis.
  • United States Patent No. 4,628,030 to Kaeppeli et al discloses a method for the production of rhamnolipids by the microorganism Pseudomonas aeruginosa.
  • rhamnolipids are produced by the cultivation of rhamnolipid producing microorganisms of the genus Pseudomonas in an aqueous culture medium suitable for the growth of the microorganism.
  • the microorganism is cultured in a continuous submerged culture under aerobic conditions and with a continuous supply of fresh culture medium, and continuous removal of a solution of partially spent culture medium and produced rhamnolipids; and limiting the amount of at least two essential growth substances selected from the group consisting of carbon, nitrogen, sulfur, phosphorous, sodium, potassium, magnesium, calcium, iron, zinc, manganese, boron, cobalt, copper and molybdenum, in the culture medium such that the quantity of essential growth substance in the partially spent culture medium is less than half of the amount in the fresh culture medium.
  • United States Patent No. 4,814,272 to Wagner et al discloses a method for the microbiological production of rhamnolipids comprising culturing the microorganism Pseudomonas species 2874 under aerobic conditions in an aqueous nutrient solution containing at least one carbon source at a pH value of 6.5 to 7.3 and a temperature of 30° to 37°C.
  • the aqueous culture is either extracted directly with a suitable solvent and evaporated, or the resulting wet cell mass is separated from the culture broth and incubated with a carbon source to further increase rhamnolipid production.
  • United States Patent No. 4,933,281 to Daniels et al discloses a method for producing rhamnose comprising the steps of growing the microorganism Pseudomonas in a defined culture medium containing vegetable oil to produce rhamnolipids; hydrolyzing the rhamnolipids to form rhamnose and 3-hydroxydecanoic acid; and separating the rhamnose from the acid.
  • sterile air is sparged into the fermentor at a rate of 0.1 to 1.0 VVM (volume air per volume fermentor liquid per minute), with a rate of 0.5 VVM being most perferred.
  • United States Patent No. 5,476,573 to Hirose et al. discloses an apparatus for defoaming and controlling aerobic culture fermentation comprising a first means for separating vapor from liquid of a foam; a second means for separating residual liquid of said vapor received from said first means for separating, in fluid communication with said first means for separating; a means for recirculating liquid from said first means for separating and condensed residual liquid from said second means for separating, said means for recirculating being in fluid communication with said first means for separating and said second means for separating, and a sensor for detecting foams, located between and in fluid communication with said first means for separating and said second means for separating.
  • an optional defoaming device may be included, which may be based on either a rotary body rotating at a high speed by use of an electric motor which beat the foams,
  • the present invention therefore, provides a process for the production of biological products by microorganisms comprising the steps of: selecting a microorganism that is capable of utilizing oxygen or an alternative oxidant source other than oxygen for cellular respiration; providing a culture medium suitable for the growth of the microorganism, wherein the medium comprises at least one carbon source; inoculating the culture medium with a desired cellular concentration of the microorganism; aerating the culture medium with oxygen, wherein the process has a maximum oxygen supply rate to the culture medium; supplying the culture medium with an alternative oxidant source, other than oxygen, such that when the cellular respiration requirements of the microorganisms within the culture medium is less than the maximum rate of oxygen supply to the culture medium, then the microorganisms will substantially utilize oxygen for cellular respiration, and when the cellular respiration requirements of the microorganisms within the culture medium is greater than the maximum rate of oxygen supply to the culture medium, then a portion of the microorganisms will utilize the available oxygen within the medium and another portion
  • the present invention also provides a process for the preparation of biological products under anaerobic respiring conditions comprising: selecting a microorganism that is capable of utilizing an alternative oxidant source other than oxygen for cellular respiration under anaerobic conditions; providing a culture medium suitable for the growth of the microorganism, wherein the medium comprises at least one carbon source; inoculating the culture medium with a desired cellular concentration of the microorganism; supplying an alternative oxidant source other than oxygen to the culture medium; maintaining the culture medium at a desired pH and temperature; and allowing the culture medium to incubate for a time sufficient to produce a desired quantity of a biological product.
  • the present invention also provides a process for creating an increased concentration of microorganisms in a defined medium comprising the steps of: selecting a microorganism that is capable of utilizing oxygen or an alternative oxidant source other than oxygen for cellular respiration; providing a culture medium suitable for the growth of the microorganism, wherein the medium comprises at least one carbon source; inoculating the culture medium with a desired cellular concentration of the microorganism; aerating the culture medium with oxygen, wherein the process has a maximum oxygen supply rate to the culture medium; supplying the culture medium with an alternative oxidant source, other than oxygen, such that when the cellular respiration requirements of the microorganisms within the culture medium is less than the maximum rate of oxygen supply to the culture medium, then the microorganisms will substantially utilize oxygen for cellular respiration, and when the oxygen requirements for cellular respiration of the microorganisms within the culture medium is greater than the maximum rate of oxygen supply to the culture medium, then a portion of the microorganisms will utilize the oxygen available within
  • Figure 1 is a graph showing the growth of Pseudomonas aeruginosa on various carbon substrates under anaerobic denitrification conditions.
  • Figure 2 is a graph showing the growth of Pseudomonas aeruginosa over time in aqueous culture media containing an initial addition of rhamnolipids as compared to growth in an aqueous medium without rhamnolipids. Cell growth is measured by the increase in cell protein (g/L).
  • Figure 3 is a graph showing Pseudomonas aeruginosa growth on a glycerol substrate under anaerobic denitrifying conditions.
  • Figure 4 is a graph showing Pseudomonas aeruginosa growth on a palmitic acid substrate under anaerobic denitrifying conditions.
  • Figure 5 is a graph showing Pseudomonas aeruginosa growth on a stearic acid substrate under anaerobic denitrifying conditions.
  • Figure 6 is a graph showing rhamnolipid production by P. aeruginosa under anaerobic denitrifying conditions followed by fermentation under aerobic conditions, using palmitic acid as the carbon source.
  • a method utilizing both aerobic and anaerobic respiration can be used to produce high cell concentrations within a culture medium, which results in an increase in the volumetric productivity of biological products, such as surfactants and viscous biopolymers.
  • biological products such as surfactants and viscous biopolymers.
  • the method of the present invention can be useful as a batch or continuous process for the production of biological materials.
  • the process of the present invention is especially useful in the production of biosurfactants, such as rhamnolipids.
  • Rhamnolipids are anionic 5 extracellular biosurfactants that are useful in many commercial applications in the petroleum, pharmaceutical and food processing industries.
  • the present invention is premised on the fact that various species of microorganisms can use certain alternative oxidants, such as nitrates and the like, other than molecular oxygen for purposes of metabolic or cellular respiration to avoid problems associated with oxygen limitation l o in bioprocesses .
  • alternative oxidant sources By using alternative oxidant sources , the serious limitations associated with oxygen supply to the cells, such as reduced cell number and foam generation can be eliminated.
  • the present invention provides a process for the production of biological 15 products by microorganisms.
  • a suitable microorganism that is capable of undergoing or utilizing anaerobic respiration must be selected.
  • a defined culture medium must be provided that is suitable for the growth of the microorganism to carry out the biological processes.
  • the medium comprises at least one carbon source for the microorganism. Once a suitable culture medium has been selected, a desired cellular concentration or 20 quantity of microorganism is introduced or added to the culture medium.
  • the culture medium is aerated with oxygen and also supplied with an alternative oxidant source.
  • the process has a maximum oxygen transfer or supply rate into the culture medium.
  • the cellular respiration requirements the oxygen 25 requirements
  • the microorganisms will utilize the oxygen within the culture medium for cellular respiration.
  • the concentration of cells within the medium begins to increase, the cellular respiration requirements, and consequently the oxygen consumption, of the microorganisms within the culture medium increases.
  • the culture medium is maintained at a desired pH and temperature, and the culture medium is allowed to incubate for a time sufficient to produce a desired quantity of a biological product.
  • the resulting biological product is isolated and recovered from the culture medium.
  • microorganisms that are useful in the present invention are those selected from bacteria, yeast, molds, archaea, and the like.
  • Preferred microorganisms are facultative aerobic bacteria and obligate anaerobic bacteria.
  • Facultative aerobic bacteria are those species of bacteria that can either utilize oxygen for respiration purposes under aerobic conditions, or can utilize alternative oxidants other than oxygen for respiration purposes in the absence of oxygen.
  • Suitable species of facultative aerobic bacteria that may be used in the present invention include, but are not limited to, nitrate/nitrite respiration bacteria such as Pseudomonas aeruginosa, Pseudomonas fluorescens, Paracoccus denitrificans , Micrococcus halodenitrificans, Klebsiella aerogenes, Escherichia coli, and the like; hyperthermophilic Archaea bacteria such as Acidianus; and the fumarate respiration bacteria such as Wolinella succinogenes, Desulfovibrio gigas, Clostridia, Escherichia coli and Proteus rettgeri.
  • a preferred facultative aerobic bacterium is that of the genus Pseudomonas.
  • the quantity or concentration of the microorganism that is added to the culture medium for processes employing growing cells is preferably from about 0.1 g/L to about 10 g/L, more preferably from about 0.5 g/L to about 5 g/L.
  • the quantity or concentration of the microorganism that is added to the culture medium is preferably from about 5 g/L to about 50 g/L.
  • the production of biological products according to the method of the present invention requires that a defined liquid culture medium be selected.
  • the liquid culture medium contains at least one carbon source (substrate) for production of biological products.
  • the liquid culture medium used in the present invention can be any known culture medium that comprises nutrients that can support cellular growth, particularly microbial growth.
  • a representative liquid culture medium formulation may comprise the following mineral substituents: 4 g/liter of NH 4 C1, 11 g/liter of K 2 HPO 4 , 0.5 g/liter NaCl, 0.3 g/liter MgSO 4 -7H 2 0, 0.03 g/liter FeCl 3 -6H 2 0, 0.01 g/liter CaCl 2 , and 0.01 g/liter MnCl 2 -4H 2 O.
  • Carbon sources useful in the present invention include, but are not limited to, fatty acids; glycerol; low molecular weight organic acids such as malate, acetate, pyruvate and the like; vegetable oil; yeast extract; peptone; and carbohydrates such as glucose.
  • Suitable fatty acids that can be utilized in the present invention include, but are not limited to, fatty acids such as palmitic acid, stearic acid, oleic acid, linoleic acid, arachidic acid, butyric acid, caproic acid, lauric acid, linolenic acid, and the like.
  • Palmitic acid is a preferred fatty acid that may be utilized in the processes of the present invention.
  • Vegetable oils such as corn oil, peanut oil, coconut oil, linseed oil, olive oil, soy bean oil, sunflower oil, and the like, may be used as the carbon substrate in the present invention.
  • a preferred vegetable oil for use in the present invention is corn oil.
  • the culture medium is simultaneously aerated with oxygen and supplied with an alternative oxidant source.
  • the population of microorganisms in the culture medium that are not utilizing oxygen for cellular respiration will utilize an alternative oxidant present in the medium instead of oxygen as the final electron acceptor in the cellular respiratory chain.
  • oxidant refers to the molecules or compounds that can serve as the terminal electron acceptor in the respiratory chain of a cell.
  • suitable alternative oxidants are selected from nitrates, nitrites, sulfates, sulfites, carbon dioxide or carbonates, bicarbonates, fumarates, sulfur, manganic ion, ferric ion, selenate, dimethyl sulfoxide, arsenate, trimethylamine-N- oxide and glycine.
  • suitable nitrates include, but are not limited to, those nitrates selected from sodium nitrate, potassium nitrate, calcium nitrate, magnesium nitrate, ammonium nitrate, nitric acid, and the like.
  • a preferred nitrate for use as the alternative oxidant source is sodium nitrate.
  • suitable nitrites include, but are not limited to, those nitrites selected from sodium nitrite, potassium nitrite, calcium nitrite, ammonium nitrites, nitrous acid and the like.
  • a preferred nitrite for use as the alternative oxidant source is sodium nitrite.
  • suitable sulfates include, but are not limited to, those sulfates that are selected from sodium sulfate, potassium sulfate, calcium sulfate, iron sulfate, magnesium sulfate, ammonium sulfate, zinc sulfate, copper sulfate, cobalt sulfate, manganese sulfate, dilute sulfur ic acid, and the like.
  • suitable sulfites include, but are not limited to, those sulfites that are selected from calcium sulfite, sodium sulfite, potassium sulfite, iron sulfite, magnesium sulfite, ammonium sulfite, zinc sulfite, copper sulfite, cobalt sulfite, manganese sulfite, and the like.
  • suitable carbonates and bicarbonates include, but are not limited to, those carbonates and bicarbonates that are selected from calcium carbonate, sodium carbonate, potassium carbonate, calcium bicarbonate, sodium bicarbonate, potassium bicarbonate, carboxylic acid, and the like.
  • Suitable fumarates useful in the present invention include, but are not limited to, those fumarates that are selected from the group consisting of disodium fumarate (C 4 H 2 O 4 Na 2 ), sodium fumarate (C 4 H 3 O 4 Na), dipotassium fumarate (C 4 H 2 O 4 K 2 ), potassium fumarate (C 4 H 3 O 4 K), fumaric acid (C 4 H 4 O 4 ), and the like.
  • the alternative oxidant is maintained in the culture medium at a concentration from about 0.01 g/L to about 10 g/L preferably at a concentration from about 0.05 g/L to about 5 g/L, and more preferably from about 0.1 g/L to about 0.5 g/L.
  • a desired amount of a surfactant may also be added to the culture medium to facilitate the mass transfer of the otherwise poorly soluble or insoluble carbon substrate into the culture medium.
  • the addition of the surfactant to the culture medium facilitates the dispersion or solubilization of the carbon source into the culture medium.
  • the addition of the surfactant to the culture medium assists in the penetration of the carbon source through the cell wall of the microorganism.
  • the amount of surfactant to be added to the culture medium is from about 0.01 g/L to about 10 g/L, preferably from about 0.05 g/L to about 1 g/L, and most preferably from about 0.1 g/L to about 0.5 g/L.
  • the microorganism is incubated with the carbon substrate contained in the culture medium for a time sufficient at a desired temperature and pH to produce a desired quantity of a biological product.
  • the temperature of the culture medium influences the growth and the survival of the microorganism employed. For every organism there is minimum temperature below which growth no longer occurs, an optimum temperature at which growth is most rapid, and a maximum temperature above which growth falls sharply to zero. Many microorganisms have temperature ranges as low as about 5°C to about 10°C, while some microorganisms have optimum temperatures greater than about 100°C.
  • microorganisms are classified into psychrophiles, having temperature optima of less than about 10°C, mesophiles, having temperature optima from about 15°C to about 45°C, thermophiles, having temperature optima of greater than about 45°C, and hyperfhermophiles having temperature optima of greater than about 80°C. Therefore, the temperature of the culture medium throughout the incubation period is dependant on the microorganism selected. For example, the temperature of the culture medium for P.
  • aeruginosa during incubation is preferably carried out in a temperature range of about 20°C to about 40 °C, more preferably in a temperature range of about.27°C to about 38 °C, and most preferably between about 30°C and about 37°C.
  • the pH of the culture medium is maintained in an optimal pH range, which is dependent on the species of microorganism chosen.
  • the present invention provides a process for the production of biosurfactants, such as rhamnolipids, by the facultative aerobic bacterium, Pseudomonas aeruginosa.
  • biosurfactants such as rhamnolipids
  • Pseudomonas aeruginosa In the absence of oxygen, Pseudomonas aeruginosa within the culture medium will utilize an alternative oxidant source, such as sodium nitrate, for cellular respiration purposes. It has been found that limiting the essential growth nutrient phosphorous from the culture media brings about the onset of the stationary phase, and facilitates increased rhamnolipid production by Pseudomonas aeruginosa.
  • the temperature range for the production of rhamnolipids by Pseudomonas aeruginosa by anaerobic denitrification is from about 20 to about 40°C, more preferably from about 27 to about 38°C, and most preferably from about 30 to about 37°C.
  • the pH range of the culture medium for the production of biosurfactants by Pseudomonas aeruginosa is optimally from about 6 to about 7, more preferably between about 6.5 to about 6.8.
  • the process of the present invention can utilize genetically engineered or manipulated host microorganisms or cells for production of biological materials, provided that the genetically engineered host cell is capable utilizing an alternative oxidant source.
  • the process including the selection of a suitable culture medium, carbon substrate, alternative oxidants and reaction conditions, is essentially the same as disclosed hereinabove, but employs genetically engineered microorganism.
  • a DNA sequence encoding for a desired biological product is selected.
  • a suitable host microorganism that is capable of undergoing anaerobic respiration is transfected with the DNA sequence, and is added to a suitable culture medium.
  • a culture medium suitable for the growth of said microorganism, and comprising at least one carbon source is provided.
  • the culture medium is inoculated with a desired cellular concentration of the microorganism.
  • An oxidant other than oxygen is supplied to the culture medium, under anaerobic conditions and in the absence of oxygen.
  • the culture medium is maintained at a desired pH and temperature, and allowed to incubate for a time sufficient to produce a desired quantity of a biological product.
  • An essential cellular growth nutrient may be substantially limited from the culture medium to inhibit cell growth and facilitate to the production of biological product.
  • obligate anaerobes can be employed as the microorganism in this embodiment.
  • Preferred obligate anaerobes are obligate anaerobic bacteria.
  • Obligate anaerobic bacteria are those species of bacteria that can only survive and grow under anaerobic conditions, that is, in the complete absence of oxygen.
  • Suitable species of obligate anaerobic bacteria include, but are not limited to, the homoacetogenic and methoanogenic Archaea bacteria capable of carbon dioxide/carbonate respiration; the sulfate-respiration bacteria such as Desulfovibrio, Desulfomonas, Desulfotomaculum, Desulfobulbus, Desulfococcus, Desulfobacter, Desulfosarcine, Desulfonema, and the like; the sulfur- respiration bacteria such as Desulfurmonas; hyperthermophilic Archaea bacteria, such as Thermoproteus, Pyrococcus, Thermococcus , and the like; and ferric ion (Fe 3+ ) respiration bacteria such as Shewanella putrefaciens .
  • the homoacetogenic and methoanogenic Archaea bacteria capable of carbon dioxide/carbonate respiration include, but are not limited to, the homoacetogenic and methoanogenic Archaea bacteria
  • An essential growth nutrient may be limited from the culture medium in order to regulate cellular growth and to reach the resting or stationary phase.
  • An essential growth nutrient that can be excluded or removed from the liquid culture media is selected from sulfur, phosphorous, nitrogen, magnesium, calcium and iron.
  • the terms "resting phase” and "stationary phase”, as used throughout the specification, refer to the phases when the cells are not undergoing cellular division.
  • biological products that can be produced according to the methods of the present invention, but are not limited to, biosurfactants, viscous biopolymers, proteins, enzymes, specialty chemicals, oxygen sensitive products, and products produced by shear sensitive microorganisms.
  • the biosurfactants that can be produced according to the methods of the present invention include, but are not limited to, rhamnolipids, sophorolipids, trehalose mycolates, trehalose esters, monosaccharide mycolates, disaccharide mycolates, trisaccharidemycolates, phospholipids, fatty acids, gramicidens, polymyxins, omithine- lipid, cerilipin, lysin-lipid, surfactin, subtilisin, peptide-lipid, heteropolysaccharide, lipoheteropolysaccharide, poly-saccharide-protein, manno-protein, carbohydrate- protein, mannan-lipid complex, mannose/erythrose-lipid, carbohydrate-protein-lipid- complex and fimbriae.
  • the viscous biopolymers that can be produced according to the methods of the present invention include, but are not limited to, xantham gum, pullulan, dextran and
  • the products produced according to the process of the present invention by shear sensitive microorganisms are selected from the group consisting of antibiotics, enzymes, cellulases, amylase, proteases, liginases, and organic acids.
  • P. aeruginosa was added to the medium to form a culture.
  • Sodium nitrate (NaNO 3 ) was included in the initial culture medium at a concentration of 0.5 g/liter of NO 3 " -N .
  • the sodium nitrate was added periodically throughout the test period to maintain the concentration of NO 3 " -N at about 0.1 to about 0.5 g/liter.
  • 16 g/liter of palmitic acid was added to the culture medium as the carbon substrate.
  • the culture medium was allowed to incubate for about 500 hours at the experimental conditions described hereinabove. The results demonstrate that rhamnolipids can be produced under anaerobic denitrification conditions, without the problems of foaming and oxygen limitation.
  • the present invention provides a process for the production of biological products, wherein a desired amount of a surfactant is added to the culture medium to 5 facilitate the mass transfer of the otherwise poorly soluble or insoluble carbon substrate into the culture medium.
  • the culture is allowed to incubate for a time sufficient to produce a desired quantity of a biological product.
  • the addition of the surfactant to the culture medium l o facilitates the dispersion or solubilization of the carbon source into the culture medium. Furthermore, the addition of the surfactant to the culture medium assists in the penetration of the carbon source through the cell wall of the microorganism.
  • the amount of surfactant to be added to the culture medium is from about 0.01 g/L to about 10 g/L, preferably from about 0.05 g/L to about 1 g/L, and most preferably from about 15 0.1 g/L to about 0.5 g/L.
  • the results indicate that rhamnolipids are produced by Pseudomonas aeruginosa under denitrifying anaerobic conditions. The rate of rhamnolipid production by anaerobic denitrification is about 2 milligrams of rhamnolipids/gram of cell protein/hour.
  • Biosurfactants such as rhamnolipids
  • rhamnolipids are extremely effective in emulsifying and solubilizing hydrocarbons and, therefore, are quite useful in oil recovery processes and mobilizing non-aqueous phase liquid contaminants in soils and aquifiers.
  • Rhamnolipids because of their antibacterial, antiviral, antifungal, and mycoplasmacidal properties, also find potential use in the pesticide applications.
  • 5 rhamnolipids have been implicated as an additive to concrete formulations to increase the strength of concrete, thus reducing the potential for concrete damage.
  • Rhamnolipids have particular application in industrial petroleum processes, including emulsification and demulsification, separation, formation of low viscosity emulsion products to transport heavy crudes, emulsion washing, formation of slurries, corrosion inhibition, enhancement of oil recovery and promotion of hydrocarbon biodegradation.
  • Biosurfactants such as rhamnolipids, are particularly useful in the cosmetic or personal hygiene industry, because of their low toxicity, excellent moisturizing properties and compatibility with mammalian skin.
  • the rhamnolipids produced according to the method of the present invention can also be used as a source of rhamnose sugar.
  • the isolated rhamnolipids are hydrolyzed to produce a mixture of rhamnose sugar and beta-hydroxydecanoic acid.
  • the rhamnose is easily separated from the beta-hydroxydecanoic acid.
  • the rhamnose can be used as a fine chemical in many industrial and scientific applications.
  • the extremely soluble alternative oxidants can be easily supplied to meet the respiration needs of high cell concentrations and, consequently, achieve very high process productivity, without the need for vigorous agitation of the culture medium within the reactor.

Abstract

L'invention concerne un procédé mettant en oeuvre des micro-organismes pour produire des produits biologiques. Le procédé consiste à choisir un micro-organisme pouvant utiliser l'oxygène ou une source oxydante substitutive autre que l'oxygène pour assurer la respiration cellulaire; à mettre en oeuvre un milieu de culture approprié pouvant favoriser la croissance du micro-organisme, ledit milieu de culture comprenant au moins une source de carbone; à injecter dans le milieu de culture une concentration cellulaire désirée du micro-organisme; à aérer le milieu de culture avec une quantité d'oxygène maximale; à alimenter le milieu de culture avec une source oxydante substitutive autre que l'oxygène afin que, lorsque les besoins des micro-organismes pour la respiration cellulaire à l'intérieur du milieu de culture sont inférieurs à la quantité maximale d'oxygène apportée au milieu de culture, les micro-organismes utilisent considérablement l'oxygène pour permettre cette respiration cellulaire, et lorsque ces besoins sont supérieurs à la quantité maximale d'oxygène apportée au milieu de culture, les micro-organismes utilisent la source oxydante substitutive pour assurer la respiration cellulaire. Le procédé consiste ensuite à maintenir le milieu de culture à un pH et à une température désirés; et à laisser le milieu de culture incuber pendant une durée suffisante pour produire une quantité désirée d'un produit biologique. L'invention concerne en outre un procédé qui permet d'augmenter la concentration de micro-organismes dans un milieu de culture donné.
PCT/US1999/026950 1998-11-18 1999-11-16 Production de matiere vivante par respiration aerobie et anaerobie simultanee WO2000029604A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17228/00A AU1722800A (en) 1998-11-18 1999-11-16 Production of biological materials by simultaneous aerobic and anaerobic respiration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10883798P 1998-11-18 1998-11-18
US60/108,837 1998-11-18

Publications (1)

Publication Number Publication Date
WO2000029604A1 true WO2000029604A1 (fr) 2000-05-25

Family

ID=22324338

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/026950 WO2000029604A1 (fr) 1998-11-18 1999-11-16 Production de matiere vivante par respiration aerobie et anaerobie simultanee

Country Status (2)

Country Link
AU (1) AU1722800A (fr)
WO (1) WO2000029604A1 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1415538A1 (fr) * 2002-11-04 2004-05-06 Puratos Naamloze Vennootschap Rhamnolipide dans des produits de boulangerie
WO2008081082A1 (fr) * 2007-01-04 2008-07-10 Eino Elias Hakalehto Procédé et équipement de production biotechnique et microbiologique
EP2434016A2 (fr) 2004-01-16 2012-03-28 Pfenex, Inc. Expression de proteines mammifères dans Pseudomonas fluorescens
CN103589765A (zh) * 2013-11-11 2014-02-19 河北鑫合生物化工有限公司 制备鼠李糖脂发酵液的方法
CN104099273A (zh) * 2014-07-11 2014-10-15 重庆市畜牧科学院 特异性分离分解氧化三甲胺的肠道细菌培养基及其制备方法和应用
CN104232708A (zh) * 2013-11-08 2014-12-24 中国科学院沈阳应用生态研究所 一种代谢产鼠李糖脂的培养基及其应用
EP2878675A1 (fr) * 2002-05-30 2015-06-03 Cargill, Incorporated Procédé de fermentation régulé par détermination du taux de consommation en oxygène spécifique
US9109229B2 (en) 2004-07-26 2015-08-18 Pfenex Inc. Process for improved protein expression by strain engineering
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN112079709A (zh) * 2019-06-12 2020-12-15 万华化学集团股份有限公司 一种由鼠李糖脂水解制备3-羟基癸酸的方法
GB2602727A (en) * 2021-01-05 2022-07-13 Norwegian Univ Of Life Sciences Method of culture
US11421258B2 (en) * 2018-08-09 2022-08-23 The University Of Akron Production of fermentation products containing rhamnolipids
EP4023763A4 (fr) * 2019-08-26 2023-08-16 National Institute Of Advanced Industrial Science and Technology Production de mel monoacyle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5501966A (en) * 1992-06-25 1996-03-26 Hoechst Aktiengesellschaft Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnose

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5501966A (en) * 1992-06-25 1996-03-26 Hoechst Aktiengesellschaft Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnose

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ATLAS R M: "HANDBOOK OF MICROBIOLOGICAL MEDIA", HANDBOOK OF MICROBIOLOGICAL MEDIA, XX, XX, 1 January 1993 (1993-01-01), XX, pages 289 - 301, XP002925955 *
VARMA AMIT ET AL.: "Stoichiometric Flux Balance Models Quantitatively Predict Growth and Metabolic By-Product Secretion in Wild-Type Escherichia coli W3110", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 60, no. 10, October 1994 (1994-10-01), pages 3724 - 3731, XP002925954 *

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2878675A1 (fr) * 2002-05-30 2015-06-03 Cargill, Incorporated Procédé de fermentation régulé par détermination du taux de consommation en oxygène spécifique
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US10041102B2 (en) 2002-10-08 2018-08-07 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US9458487B2 (en) 2002-10-08 2016-10-04 Pfenex, Inc. Expression of mammalian proteins in pseudomonas fluorescens
WO2004040984A1 (fr) * 2002-11-04 2004-05-21 Puratos Naamloze Vennootschap Rhamnolipides dans des produits de boulangerie
EP1415538A1 (fr) * 2002-11-04 2004-05-06 Puratos Naamloze Vennootschap Rhamnolipide dans des produits de boulangerie
EP2434016A2 (fr) 2004-01-16 2012-03-28 Pfenex, Inc. Expression de proteines mammifères dans Pseudomonas fluorescens
US9109229B2 (en) 2004-07-26 2015-08-18 Pfenex Inc. Process for improved protein expression by strain engineering
WO2008081082A1 (fr) * 2007-01-04 2008-07-10 Eino Elias Hakalehto Procédé et équipement de production biotechnique et microbiologique
US10689640B2 (en) 2007-04-27 2020-06-23 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN104232708A (zh) * 2013-11-08 2014-12-24 中国科学院沈阳应用生态研究所 一种代谢产鼠李糖脂的培养基及其应用
CN103589765A (zh) * 2013-11-11 2014-02-19 河北鑫合生物化工有限公司 制备鼠李糖脂发酵液的方法
WO2016004658A1 (fr) * 2014-07-11 2016-01-14 重庆市畜牧科学院 Milieu de culture permettant de séparer de manière spécifique des bactéries intestinales capables de décomposer le n-oxyde de triméthylamine, son procédé de préparation et son utilisation
CN104099273A (zh) * 2014-07-11 2014-10-15 重庆市畜牧科学院 特异性分离分解氧化三甲胺的肠道细菌培养基及其制备方法和应用
US11421258B2 (en) * 2018-08-09 2022-08-23 The University Of Akron Production of fermentation products containing rhamnolipids
CN112079709A (zh) * 2019-06-12 2020-12-15 万华化学集团股份有限公司 一种由鼠李糖脂水解制备3-羟基癸酸的方法
CN112079709B (zh) * 2019-06-12 2023-03-28 万华化学集团股份有限公司 一种由鼠李糖脂水解制备3-羟基癸酸的方法
EP4023763A4 (fr) * 2019-08-26 2023-08-16 National Institute Of Advanced Industrial Science and Technology Production de mel monoacyle
GB2602727A (en) * 2021-01-05 2022-07-13 Norwegian Univ Of Life Sciences Method of culture
WO2022148791A1 (fr) 2021-01-05 2022-07-14 Norwegian University Of Life Sciences Procédé de culture

Also Published As

Publication number Publication date
AU1722800A (en) 2000-06-05

Similar Documents

Publication Publication Date Title
Chayabutra et al. Rhamnolipid production by Pseudomonas aeruginosa under denitrification: effects of limiting nutrients and carbon substrates
WO2000029604A1 (fr) Production de matiere vivante par respiration aerobie et anaerobie simultanee
Yeh et al. Bioreactor design for enhanced carrier-assisted surfactin production with Bacillus subtilis
EP3659982B1 (fr) Composition bio-catalytique utile dans le conditionnement de sols
Duvnjak et al. Production of surfactant by Arthrobacter paraffineus ATCC 19558
Markossian et al. Isolation and characterization of lipid-degrading Bacillus thermoleovorans IHI-91 from an icelandic hot spring
Lee et al. Rhamnolipid production in batch and fed-batch fermentation using Pseudomonas aeruginosa BYK-2 KCTC 18012P
Felse et al. Submerged culture production of chitinase by Trichoderma harzianum in stirred tank bioreactors–the influence of agitator speed
Shah et al. Isolation and characterization of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) degrading bacteria and purification of PHBV depolymerase from newly isolated Bacillus sp. AF3
US11279965B2 (en) Symbiotic fermentation of Acinetobacter and Bacillus and applications thereof
Baharum et al. Organic solvent tolerant lipase by Pseudomonas sp. strain S5: stability of enzyme in organic solvent and physical factors effecting its production
US20050136517A1 (en) Process for production of exopolysaccharides
Noah et al. Surfactin production from potato process effluent by Bacillus subtilis in a chemostat
EP3458615A1 (fr) Procédé biotechnologique pour la production d'acrylamide et nouvelle souche bactérienne relative
Fooladi et al. Enhanced biosurfactant production by Bacillus pumilus 2IR in fed-batch fermentation using 5-L bioreactor
Furuhashi et al. Optimization of a medium for the production of 1, 2-epoxytetradecane by Nocardia corallina B-276
Kosseva et al. Thermophilic bioremediation strategies for a dairy waste
GB2090847A (en) A continuous process for the production of gelable exopolysaccharide
WO2008126669A2 (fr) Procédé de production d'acide pyruvique
Bhushan et al. Lipase production from an alkalophilic yeast sp. by solid state fermentation
CN106544293A (zh) 一种使用毕赤酵母发酵菌泥生产丁酸梭菌的方法
Bastida et al. Biotransformation of oleic acid into 10-hydroxy-8 E-octadecenoic acid by Pseudomonas sp. 42A2
JP2579595B2 (ja) 新規微生物および該微生物を用いた２，６−ナフタレンジカルボン酸の製造法
Parvanova-Mancheva et al. Biodegradation potential of Pseudomonas putida to phenol compared to Xanthobacter autotrophicus GJ10 and Pseudomonas denitrificans strains
Rahman et al. A new thermostable lipase by Aneurinibacillus thermoaerophilus strain HZ: nutritional studies

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 17228

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 09830894

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase